Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

8 results about "Heartburn" patented technology

A sensation of painful burning in the upper chest.

Traditional Chinese medicine composition for treating gastroesophageal reflux

PendingCN121059748ADigestive systemPlant ingredientsGastro-esophageal reflux diseaseTraditional medicine
The invention discloses a traditional Chinese medicine composition for treating gastroesophageal reflux. The invention belongs to the technical field of traditional Chinese medicine. The traditional Chinese medicine composition is prepared from rhizoma bletillae, bulbus fritillariae thunbergii, cuttlebone, calcined concha arcae, fructus amomi and the like. The traditional Chinese medicine composition has the effects of relieving hyperacidity and pain, and regulating qi and harmonizing stomach. The traditional Chinese medicine composition disclosed by the invention has an excellent clinical effect in treating the gastroesophageal reflux disease, is mild in medicine property of the whole formula, is suitable for various syndromes of the gastroesophageal reflux disease, and is particularly suitable for patients with heartburn, sour regurgitation and belching, chest distress, inappetence, vomiting, throat discomfort, light red tongue, white fur and slippery pulse caused by phlegm-heat and qi stagnation.
Owner:WANGJING HOSPITAL OF CHINA ACAD OF CHINESE MEDICAL SCI

Traditional Chinese medicine composition and application thereof

The invention discloses a traditional Chinese medicine composition and application thereof, raw material medicines of the traditional Chinese medicine composition comprise first raw material medicines, and the first raw material medicines comprise 10-40 parts by weight of mangnolia officinalis, 10-60 parts by weight of astragalus membranaceus, 10-40 parts by weight of bighead atractylodes rhizome, 10-40 parts by weight of curcuma zedoary, 5-40 parts by weight of rhizoma bletillae and 5-40 parts by weight of rhizoma zingiberis; the raw material medicine of the traditional Chinese medicine composition further comprises a second raw material medicine, and the second raw material medicine is pseudo-ginseng; the weight ratio of the first raw material medicine to the second raw material medicine is (15-17): (1-12). The traditional Chinese medicine composition can effectively relieve digestive tract discomfort symptoms caused by chronic atrophic gastritis, can effectively improve the pathological state of gastrointestinal tract tissues, reverses the pathological states of stomach tissue atrophy, intestinal metaplasia and / or dysplasia and the like, relieves gastrointestinal tract disease symptoms such as poor appetite, abdominal distension, fullness, belching, sour regurgitation and heartburn in the past, and improves the curative effect of chronic atrophic gastritis. And the traditional Chinese medicine composition is simple in taking method, low in dosage and high in clinical value.
Owner:贾波 +4

Traditional Chinese medicine composition and application thereof in preparation of medicine for treating reflux esophagitis

The invention provides a traditional Chinese medicine composition and application thereof in preparation of a medicine for treating reflux esophagitis, and relates to the technical field of traditional Chinese medicine pharmacy. According to the traditional Chinese medicine composition, thunberg fritillary bulb, fructus evodiae and fingered citron serve as monarch drugs, inula flower, buckeye, rhizoma nardostachyos, clove, amomum tsao-ko and membrane of hen egg serve as ministerial drugs, nacre mother of pearl, cortex fraxini, felwort, sweet-scented osmanthus and reed rhizome serve as adjuvant drugs, licorice serves as conductant drugs, and all the drugs are combined to achieve the effects of soothing the liver and harmonizing the stomach, calming the adverse-rising energy, relieving acid and regulating cold and heat. The traditional Chinese medicine composition can significantly improve the esophagitis index of RE rats, has an obvious inhibition effect on inflammatory injury, can significantly improve the pathological morphology of esophageal tissues of the RE rats, and achieves good anti-inflammatory and therapeutic effects on the RE rats. Meanwhile, the traditional Chinese medicine composition can remarkably improve and relieve clinical symptoms such as sour regurgitation, heartburn, abdominal distension and belching of reflux esophagitis patients, and the attack frequency of the clinical symptoms is reduced. The traditional Chinese medicine composition disclosed by the invention is expected to be further developed and popularized as a medicine for treating reflux esophagitis.
Owner:THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIV

Application of Wangshi Bachi Pills in the Treatment of Helicobacter Pylori Infection

ActiveCN117503865BMicrobiologyHelicobacter Infections
The application discloses application of Wangshi Baochi pills in treatment of Helicobacter pylori infection and belongs to the technical field of medicines. The application provides the application of the Wangshi Baochi pills in treatment of Helicobacter pylori infection, which can achieve ideal treatment effects under the condition that the dosage of antibiotics is halved and bismuth agents are not used, and can better relieve the clinical symptoms of pain, belching, acid regurgitation and heartburn.
Owner:JINGHUA PHARMA GRP

Pharmaceutical Formulations and Methods for the Treatment of Gastrointestinal Disorders

PendingUS20260125373A1Organic active ingredientsDigestive systemDisease irritable bowelDisease
Provided herein is a bulk composition comprising the trihydrate form of (3S, 4R, 3′R)-6-[4-(4-amino-5-chloro-2-methoxy-benzoylamino)-3-methoxy-piperidin-1-yl]-hexanoic acid 1-azabicyclo[2.2.2]oct-3′-yl ester di-hydrochloride salt. Provided are also pharmaceutical compositions and dosage forms comprising the trihydrate form, and methods and uses for treating a gastrointestinal disorder in a subject with the trihydrate form. In some embodiments, the gastrointestinal disorder is gastroesophageal reflux disease (GERD), dyspepsia (such as functional dyspepsia or functional motility disorder), gastroparesis, paralytic ileus, post-operative ileus, emesis, nausea, heartburn, intestinal pseudo-obstruction, irritable bowel syndrome (IBS), constipation, enteral feeding intolerance (EFI), or esophagitis. In some embodiments, the gastrointestinal disorder is post-operative ileus, chronic grass sickness, constipation, megacolon, gastritis, gastrointestinal stasis, or abomasal emptying defect.
Owner:RENEXXION LLC

Unit oral dose compositions composed of ibuprofen or a pharmaceutically acceptable salt thereof and famotidine or a pharmaceutically acceptable salt thereof for the treatment of acute pain and the reduction of the severity and / or risk of heartburn and / or upset stomach

Described herein are unit oral dose compositions that reduce the severity of heartburn and / or upset stomach or the risk of the occurrence of heartburn and / or upset stomach in a human in need of taking ibuprofen or the pharmaceutically acceptable salt thereof for the treatment of acute pain wherein the human is not experiencing heartburn and / or upset stomach prior to the oral administration of the unit oral dose composition comprising orally administering to the human of a unit oral dose composition comprising (i) ibuprofen or the pharmaceutically acceptable salt thereof, wherein the amount of ibuprofen or the conjugate base of ibuprofen of the pharmaceutically acceptable salt of ibuprofen is a dosage from about 50 mg to about 400 mg per unit oral dose composition and (ii) famotidine or the pharmaceutically acceptable salt thereof, wherein famotidine or the conjugate acid of famotidine of the pharmaceutically acceptable salt of famotidine is at a dosage from about 3 mg to about 20 mg per unit oral dose composition, wherein the dissolution rate of famotidine or the conjugate acid of famotidine of the pharmaceutically acceptable salt of famotidine in the unit oral dose composition in said human at a specified time within 45 minutes of administration of said unit oral dose composition to said human is greater than the dissolution rate of ibuprofen or the conjugate base of ibuprofen of the pharmaceutically acceptable salt of ibuprofen in the unit oral dose composition in said human at the same specified time.
Owner:SCHABAR RESEARCH ASSOCIATES LLC

Acid reflux and heartburn curing composition

An easy-to-administer capsule containing a composition for quickly providing relief from acid reflux and heartburn. The capsule is orally administered and the composition includes mustard powder and turmeric powder. In one embodiment, ginger root extract, probiotic blends, and digestive enzyme blends are also included in the composition. The composition starts providing relief within 10 minutes and provides relief for about 12 hours. The composition is available in the form of capsules or powder. The composition is natural and organic and the capsule disintegrates inside the gut of a human.
Owner:MOORE DARLENE

Traditional Chinese medicine composition for treating gastroesophageal reflux

InactiveCN120884667ADigestive systemPlant ingredientsWolfiporia cocosHeartburn
The invention discloses a traditional Chinese medicine composition for treating gastroesophageal reflux. The invention belongs to the technical field of traditional Chinese medicine. The traditional Chinese medicine composition is prepared from rhizoma bletillae, bulbus fritillariae thunbergii, cuttlebone, calcined concha arcae, fructus amomi and the like. The traditional Chinese medicine composition has the effects of relieving hyperacidity and pain, and regulating qi and harmonizing stomach. The traditional Chinese medicine composition disclosed by the invention has an excellent clinical effect in treating the gastroesophageal reflux disease, is mild in medicine property of the whole formula, is suitable for various syndromes of the gastroesophageal reflux disease, and is particularly suitable for patients with heartburn, sour regurgitation and belching, chest distress, inappetence, vomiting, throat discomfort, light red tongue, white fur and slippery pulse caused by phlegm-heat and qi stagnation.
Owner:WANGJING HOSPITAL OF CHINA ACAD OF CHINESE MEDICAL SCI